ZyVersa Therapeutics Inc (ZVSA) concluded trading on Wednesday at a closing price of $0.68, with 66.65 million shares of worth about $45.32 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -64.15% during that period and on May 07, 2025 the price saw a gain of about 24.24%. Currently the company’s common shares owned by public are about 3.62M shares, out of which, 3.61M shares are available for trading.
Stock saw a price change of 12.28% in past 5 days and over the past one month there was a price change of 17.66%. Year-to-date (YTD), ZVSA shares are showing a performance of -35.40% which decreased to -87.43% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.55 but also hit the highest price of $6.69 during that period. The average intraday trading volume for ZyVersa Therapeutics Inc shares is 2.44 million. The stock is currently trading -3.03% below its 20-day simple moving average (SMA20), while that difference is down -12.22% for SMA50 and it goes to -58.80% lower than SMA200.
ZyVersa Therapeutics Inc (NASDAQ: ZVSA) currently have 3.62M outstanding shares and institutions hold larger chunk of about 2.24% of that.
The stock has a current market capitalization of $2.48M and its 3Y-monthly beta is at 0.66. It has posted earnings per share of -$11.58 in the same period. It has Quick Ratio of 0.15 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZVSA, volatility over the week remained 14.18% while standing at 30.94% over the month.
